Medtronic plc today announced three-month results from a large, multicenter randomized controlled trial showing statistically significant (p=0.0009) and superior back pain relief with Differential Target Multiplexed (DTM) Spinal Cord Stimulation (SCS) compared to conventional SCS.
Read More
Health Rss 